Suppression of ABIN-1 may not be necessary in underexpressed CRC tissues, but in tumor tissues with normal or overexpression of ABIN-1, targeting ABIN-1 to enhance necroptosis-based therapy may be beneficial. This evidence concerns the gene TNIP1 and colorectal carcinoma.